How much is General Medicine worth in 2026?

General Medicine has a current valuation of N/A based on their Early Stage VC round and secondary market data.

How much funding has General Medicine raised?

General Medicine has raised N/A in total funding across 1 funding rounds.

General Medicine

Information Services (B2C)

General Medicine valuation and funding history | Last updated: May 22, 2025 | 1 funding rounds

Current Valuation

N/A

As of May 22, 2025

Total Funding Raised

N/A

Across 1 round

Last Round

Early Stage VC

$32.0M

Last Funding

May 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
May 22, 2025	Early Stage VC	$32.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

General Medicine is currently valued at N/A as of May 22, 2025.

Track General Medicine Valuation Updates

Get notified when General Medicine raises new funding or valuation changes

Explore More Data

Detailed analysis for General Medicine

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock General Medicine's valuation history, funding rounds, and growth metrics.

No credit card required

What is General Medicine Worth in 2026?

General Medicine is a leading private company in the Information Services (B2C) sector. Track General Medicine's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How General Medicine Valuation is Determined

Private company valuations like General Medicine's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.